Proof of mechanism (POM) in the first-in-human trial of two novel indenoisoquinoline, non-camptothecin topoisomerase I (TOP1) inhibitors.
James H. Doroshow
No relevant relationships to disclose
Jiuping Jay Ji
No relevant relationships to disclose
Alice Chen
No relevant relationships to disclose
Deborah Allen
No relevant relationships to disclose
Yiping Zhang
No relevant relationships to disclose
Scott M Lawrence
No relevant relationships to disclose
Thomas D. Pfister
No relevant relationships to disclose
Lihua Wang
No relevant relationships to disclose
Christophe E. Redon
No relevant relationships to disclose
William Bonner
No relevant relationships to disclose
Giovanna Speranza
No relevant relationships to disclose
Marcie K. Weil
No relevant relationships to disclose
Julie Eiseman
No relevant relationships to disclose
Julianne L. Holleran
No relevant relationships to disclose
Robert J. Kinders
No relevant relationships to disclose
Jan Hendrik Beumer
No relevant relationships to disclose
Ralph E. Parchment
No relevant relationships to disclose
Yves Pommier
No relevant relationships to disclose
Joseph E. Tomaszewski
No relevant relationships to disclose
Shivaani Kummar
No relevant relationships to disclose